BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15153843)

  • 1. Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.
    Ehtesham M; Black KL; Yu JS
    Cancer Control; 2004; 11(3):192-207. PubMed ID: 15153843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
    Akasaki Y; Black KL; Yu JS
    Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immunotherapeutic approaches to glioma.
    Yamanaka R
    Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for glioma: promises and challenges.
    Han SJ; Zygourakis C; Lim M; Parsa AT
    Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
    Mitra S; Li G; Harsh GR
    Neurosurg Clin N Am; 2010 Jan; 21(1):67-76. PubMed ID: 19944967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.
    Ryu JI; Han MH; Cheong JH; Kim JM; Kim CH
    Immunotherapy; 2017 Mar; 9(5):411-421. PubMed ID: 28357913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Based Immunotherapy of Gliomas.
    Everson RG; Antonios JP; Liau LM
    Prog Neurol Surg; 2018; 32():90-100. PubMed ID: 29990977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
    Pollack IF; Okada H; Chambers WH
    Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-based active specific immunotherapy for malignant glioma.
    Parajuli P; Mathupala S; Mittal S; Sloan AE
    Expert Opin Biol Ther; 2007 Apr; 7(4):439-48. PubMed ID: 17373896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
    Yang L; Ng KY; Lillehei KO
    Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic strategies for malignant glioma.
    Fenstermaker RA; Ciesielski MJ
    Cancer Control; 2004; 11(3):181-91. PubMed ID: 15153842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dendritic cell therapy for malignant glioma].
    Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
    No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in clinical design of immunotherapy trials for malignant glioma.
    Rolle CE; Sengupta S; Lesniak MS
    Neurosurg Clin N Am; 2010 Jan; 21(1):201-14. PubMed ID: 19944979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell vaccines.
    Yamanaka R; Kajiwara K
    Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-based glioma immunotherapy (review).
    Yamanaka R; Yajima N; Abe T; Tsuchiya N; Homma J; Narita M; Takahashi M; Tanaka R
    Int J Oncol; 2003 Jul; 23(1):5-15. PubMed ID: 12792771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.
    Weller M; Fontana A
    Brain Res Brain Res Rev; 1995 Sep; 21(2):128-51. PubMed ID: 8866671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances and future of immunotherapy for glioblastoma.
    Kamran N; Calinescu A; Candolfi M; Chandran M; Mineharu Y; Asad AS; Koschmann C; Nunez FJ; Lowenstein PR; Castro MG
    Expert Opin Biol Ther; 2016 Oct; 16(10):1245-64. PubMed ID: 27411023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.